Concepedia

Johannes Sam

JS

24

Publications

2.4K

Citations

22

H-Index

1989

Active since

Affiliations

Roche (Switzerland)(Current)

Roche Pharma AG (Germany)

University of Basel

Institute for Biomedical Engineering

Wake Forest University

Johannes Sam is an author at Roche (Switzerland) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1989–2024

24

Publications

24

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 342 citations · Full text

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 252 citations · Full text

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 238 citations · Full text

CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

Marina Bacac, Sara Colombetti, Sylvia Herter et al. · Clinical Cancer Research · 2018 · 223 citations

CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

Isabelle Solomon, Maria Amann, Anne Goubier et al. · Nature Cancer · 2020 · 184 citations · Full text

, , +10

Rows per page

1–5 of 24